GeNeuro (XPAR:GNRO) Short Interest


XPAR:GNRO GeNeuro SA XPAR:GNRO
8 GF Score
Price €0.03
View Full Analysis

What is GeNeuro Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XPAR:GNRO vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, GeNeuro's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeNeuro Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeNeuro's Short Interest distribution charts can be found below:

* The bar in red indicates where GeNeuro's Short Interest falls into.


XPAR:GNRO
8GF Score
GeNeuro SA XPAR:GNRO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GeNeuro Business Description

Address 3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
8GF Score

Get the complete analysis for XPAR:GNRO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price